Digital Biomarker in Neurological Patient-Centric Ecosystem
Jul 16, 2021
1 min readAdd to Favourite
We helped a leading molecular diagnostic, personalized medicine company to adequately understand and prioritize State-of-the-art Technology related to digital biomarkers in the neurological patient-centric ecosystem and potential partners who could address the technology and regulatory challenges. By leveraging FutureBridge exclusive research advisory framework, the intelligence enabled the comprehensive understanding of the complex space and key hurdles related to clinical adoption of digital biomarkers, competitive landscape, and partnering opportunities. The benchmarking and prioritized matrices supported clients to develop an attractive proposition for their innovative patient care ambitions.